Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)
Hong Kong · Delayed Price · Currency is HKD 18.40
-0.30 (-1.60%)
Jun 18, 2026, 4:08 PM HKT
HKG:2190 Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, HKG:2190 stock has a consensus rating of "Strong Buy" and an average price target of $30.99. The average 1-year stock price forecast is 68.42% higher than the current stock price, while the lowest is $29.64 (+61.09%) and the highest is $32.50 (+76.63%).
Price Target: $30.99 (+68.42%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 28, 2026.
Analyst Ratings
The average analyst rating for HKG:2190 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Nov '25 | Dec '25 | Jan '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $29.65 | Buy | Maintains | $29.65 | +61.14% | Mar 28, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $29.00 | Buy | Maintains | $29.00 | +57.61% | Mar 26, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $32.00 | Buy | Maintains | $32.00 | +73.91% | Mar 20, 2026 |
Unknown Analyst Guoyuan Securities (HK) No rating | Guoyuan Securities (HK) | Buy Maintains $28.35 | Buy | Maintains | $28.35 | +54.08% | Dec 20, 2025 |
Financial Forecast
Revenue This Year
1.47B
from 1.06B
Increased by 39.16%
Revenue Next Year
1.88B
from 1.47B
Increased by 27.98%
EPS This Year
1.05
from 0.84
Increased by 24.04%
EPS Next Year
1.35
from 1.05
Increased by 28.66%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.5B | ||
| Avg | 1.5B | ||
| Low | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 44.0% | ||
| Avg | 39.2% | ||
| Low | 31.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.08 | ||
| Avg | 1.05 | ||
| Low | 0.99 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.0% | ||
| Avg | 24.0% | ||
| Low | 17.3% |